1049 related articles for article (PubMed ID: 16202357)
21. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
[TBL] [Abstract][Full Text] [Related]
22. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
Kunz J; Gottschalk J; Jänisch W; Schulz W
Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
[TBL] [Abstract][Full Text] [Related]
23. Alpha-1-antichymotrypsin in human glioblastoma multiforme cells and its relation to GFAP immunostaining.
Kroh H; Cervós-Navarro J
Clin Neuropathol; 1991; 10(4):181-6. PubMed ID: 1653125
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical study of human brain tumors with vimentin and astroprotein (GFAP)].
Maruno M; Yoshimine T; Ushio Y; Hayakawa T; Jamshidi J; Arita N; Bitoh S; Mogami H
No To Shinkei; 1987 Jun; 39(6):579-85. PubMed ID: 3304361
[TBL] [Abstract][Full Text] [Related]
25. Morphological pattern and frequency of intracranial tumours in children.
Hanif G; Shafqat S
J Coll Physicians Surg Pak; 2004 Mar; 14(3):150-2. PubMed ID: 15228847
[TBL] [Abstract][Full Text] [Related]
26. Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: adaptation to the microenvironment.
Herpers MJ; Budka H; McCormick D
Acta Neuropathol; 1984; 64(4):333-8. PubMed ID: 6391069
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical study of ethylnitrosourea-induced rat gliomas with vimentin and astroprotein (GFAP)].
Maruno M; Yoshimine T; Ushio Y; Hayakawa T; Jamshid J; Bitoh S; Mogami H
No To Shinkei; 1985 Dec; 37(12):1173-9. PubMed ID: 4091986
[TBL] [Abstract][Full Text] [Related]
28. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
29. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
[TBL] [Abstract][Full Text] [Related]
31. Astrocytes in brain tumours. Differentiation or trapping?
Escalone Zapata J
Histol Histopathol; 1994 Apr; 9(2):325-32. PubMed ID: 8075493
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion.
Suzuki T; Izumoto S; Fujimoto Y; Maruno M; Ito Y; Yoshimine T
J Clin Pathol; 2005 Feb; 58(2):166-71. PubMed ID: 15677537
[TBL] [Abstract][Full Text] [Related]
33. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
[TBL] [Abstract][Full Text] [Related]
34. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
35. Localization of glial fibrillary acidic protein in retinal astrocytoma: an immunohistochemical study.
Jiang Q; Fratkin JD; Blodi FC
Curr Eye Res; 1982-1983; 2(8):523-7. PubMed ID: 6820938
[TBL] [Abstract][Full Text] [Related]
36. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
37. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
[TBL] [Abstract][Full Text] [Related]
38. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
39. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
Khalanskiĭ AS; Shevchenko GM; Berezin VA
Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
[TBL] [Abstract][Full Text] [Related]
40. Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
